TL;DR
This paper explores the use of a traditional Chinese medicine formula, Qing-Hao-Bie-Jia decoction (QHBJD), for managing fever in lung cancer patients. By reviewing historical texts and modern case reports, the authors propose a framework for integrating ancient TCM principles with contemporary clinical practice to improve patient outcomes.
What Problem Does This Paper Address?
Cancer-related fever (CRF) is a common and debilitating symptom in cancer patients, significantly impacting their quality of life and survival. While modern medicine offers symptomatic relief, challenges remain with recurrence and side effects. Traditional Chinese Medicine (TCM) has long offered approaches to managing such fevers, often conceptualized as "endogenous heat." This paper specifically addresses the gap in understanding and applying TCM treatments, particularly QHBJD, for lung cancer-related fever (LCRF) by bridging historical TCM theory with current clinical evidence.
Methods
The study employed a three-pronged approach:
- Historical Review: The origins and ancient applications of QHBJD were traced through classical Chinese medical texts.
- Systematic Review: A systematic review of published case reports on the use of QHBJD for LCRF was conducted across multiple databases (CNKI, WanFang, VIP, CBM, PubMed, Web of Science). The review focused on case reports (PICO framework: Patient, Intervention, Study) and assessed methodological quality using the JBI critical appraisal checklist.
- Case Report: A detailed case report of a lung cancer patient successfully treated with a QHBJD-derived supplementary formula (QHBJD-SF) was presented, adhering to CARE and CARC guidelines.
Datasets
Not explicitly discussed in the paper as distinct datasets. The study utilized:
- Ancient TCM Texts: For historical context and understanding of QHBJD's origins.
- Published Case Reports: A collection of eight case reports on LCRF treated with QHBJD-SF, identified through systematic literature searches.
- Patient Data: A single case report detailing a patient's medical history, diagnostic assessments, clinical findings, and treatment outcomes.
Key Insights and Ideas
- "Latent Heat in the Yin" as a Key Pathogenesis: The study identifies "latent heat in the Yin" as a predominant TCM pathogenesis for cancer-related fever in lung cancer patients. This concept aligns with the TCM principle of nourishing Yin and outthrusting heat.
- Flexibility in QHBJD Application: While QHBJD is a foundational formula, TCM practitioners adapt it by adding or subtracting herbs (creating QHBJD-SFs) to tailor treatments to individual patient syndromes and conditions.
- Bridging Ancient and Modern: The paper successfully demonstrates how ancient TCM theories about fever management can be applied and validated through modern clinical case reports, providing a framework for evidence-based TCM.
- Importance of Individualization: The study highlights that cancer patients often require highly personalized treatment regimens, a principle well-suited to TCM's syndrome differentiation approach.
Key Results
- Systematic Review Findings: Eight eligible case reports were identified, involving patients aged 33-81 years. The primary TCM syndrome diagnosed was "Yin deficiency leading to internal heat" (YDIH) or "dual deficiency of Qi and Yin." All patients in the reviewed cases achieved defervescence without recurrent fever during follow-up.
- Case Report Success: A 46-year-old male with persistent low-grade fever post-lung cancer surgery was successfully treated with a QHBJD-SF. His fever completely resolved, and he experienced no recurrence during follow-up.
- Methodological Quality: While case reports provided valuable insights, the study noted limitations in the reporting of patient history and adverse events across the included studies.
Limitations and Future Work
- Limitations:
- Limited Ancient Evidence: The study acknowledges that the compilation and digitization of ancient TCM literature may not capture all available historical evidence.
- Low-Level Evidence: Case reports, by nature, represent Level V evidence in TCM studies and are considered very low certainty in the GRADE system.
- Lack of Control Groups: The reviewed case reports and the presented case report did not involve control groups, limiting definitive conclusions about causality.
- Inconsistent Reporting: Gaps were identified in the reporting of patient history, diagnostic tests, and adverse events in the reviewed case reports.
- Future Work:
- Prospective Studies: The authors emphasize the need for more prospective studies with rigorously designed protocols to complement the findings from case reports and strengthen the evidence base.
- Enhanced Safety Reporting: Future research should prioritize comprehensive reporting of adverse drug reactions and events.
- Standardized Reporting: Developing and adhering to standardized reporting guidelines for TCM case reports would improve the quality and comparability of future studies.
Summary updated